| 1 |
33554122 | Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target. | 2021 Mar |
4 |
| 2 |
33791156 | Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment. | 2021 |
1 |
| 3 |
34230470 | EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer. | 2021 Jul 6 |
1 |
| 4 |
34314419 | Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells. | 2021 Jul |
1 |
| 5 |
32321643 | Serine mutation of a conserved threonine in the hERG K+ channel S6-pore region leads to loss-of-function through trafficking impairment. | 2020 Jun 11 |
1 |
| 6 |
28887309 | Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation. | 2017 Oct 20 |
7 |
| 7 |
27055868 | MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation. | 2016 Jul |
3 |
| 8 |
23918819 | Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions. | 2013 Nov |
3 |
| 9 |
16291873 | Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs. | 2006 Feb |
1 |
| 10 |
10354437 | Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel. | 1999 Jun |
1 |